SAN

80.94

+0.38%↑

SHL.DE

42.28

+1%↑

PHIA

26.89

+0.9%↑

SRT3

238

-0.17%↓

ORNBV.FI

67.95

-0.22%↓

SAN

80.94

+0.38%↑

SHL.DE

42.28

+1%↑

PHIA

26.89

+0.9%↑

SRT3

238

-0.17%↓

ORNBV.FI

67.95

-0.22%↓

SAN

80.94

+0.38%↑

SHL.DE

42.28

+1%↑

PHIA

26.89

+0.9%↑

SRT3

238

-0.17%↓

ORNBV.FI

67.95

-0.22%↓

SAN

80.94

+0.38%↑

SHL.DE

42.28

+1%↑

PHIA

26.89

+0.9%↑

SRT3

238

-0.17%↓

ORNBV.FI

67.95

-0.22%↓

SAN

80.94

+0.38%↑

SHL.DE

42.28

+1%↑

PHIA

26.89

+0.9%↑

SRT3

238

-0.17%↓

ORNBV.FI

67.95

-0.22%↓

Strona główna・Stock List・Vetoquinol SA

Vetoquinol SA

Closed

SectorHealthcare

84.7 0.36

Buy Sell

Overview

Share price change

24h

Current

Min

83.8

Max

Key metrics
By Trading Economics
Income	25M
Sales	258M
P/E Sector Avg	16.706 108.767
Dividend yield	1.03
Profit margin	9.734
Employees	2,497
EBITDA	48M

Dividends
By Dow Jones
Dividend yield Sector Avg	1.03% 2.21%
Next Earnings	27 mar 2026

Market Stats
By TradingEconomics
Market Cap	1B
Previous open	84.34
Previous close	84.7

News Sentiment

By Acuity

50%

167 / 351 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

72.6 / 75.1 Support & Resistance

Vetoquinol SA Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

25 lut 2026, 23:25 UTC

Hot Stocks

Stocks to Watch: C3.ai, Salesforce, Pure Storage, Zoom

25 lut 2026, 23:15 UTC

Earnings

Salesforce Sees Stable Growth; CEO Dismisses Talk of AI-Fueled 'SaaS-Pocalypse' -- 2nd Update

25 lut 2026, 23:54 UTC

Market Talk

Gold Steady Ahead of U.S.-Iran Talks -- Market Talk

25 lut 2026, 23:47 UTC

Earnings

Ferrovial 4Q Net EUR197M >FER.MC

25 lut 2026, 23:45 UTC

Earnings

Ferrovial 4Q Rev EUR2.72B >FER.MC

25 lut 2026, 23:42 UTC

Earnings

Nvidia Beats Back Bubble Fears With Record $68 Billion Sales in Fourth Quarter -- 4th Update

25 lut 2026, 23:38 UTC

Market Talk

Nikkei May Rise, Tracking Wall Street's Gains -- Market Talk

25 lut 2026, 23:25 UTC

Earnings

Trip.com: Company's Business Operations Remain Normal >TCOM

25 lut 2026, 23:25 UTC

Earnings

Trip.com Gives Update on Investigation by China's State Administration for Market Regulation >TCOM

25 lut 2026, 23:25 UTC

Earnings

Trip.com: Cannot Predict Status or Results of Investigation, Will Provide Updates on Conclusion >TCOM

25 lut 2026, 23:25 UTC

Earnings

Trip.com Increase in FY Profit Primarily Due to Gain From Investments >TCOM

25 lut 2026, 23:25 UTC

Earnings

Trip.com Will Continue to Communicate With SAMR on Compliance With Regulatory Requirements >TCOM

25 lut 2026, 23:25 UTC

Earnings

Trip.com: SAMR Investigation Related to China's Anti-monopoly Law >TCOM

25 lut 2026, 23:25 UTC

Earnings

Trip.com: Investigation Ongoing, Company Is Cooperating With SAMR >TCOM

25 lut 2026, 23:25 UTC

Earnings

Trip.com Co-founders Min Fan, Qi Ji Resign From Positions >TCOM

25 lut 2026, 23:25 UTC

Earnings

Trip.com: Fan Resigned as Director and President; Ji Resigned as a Director >TCOM

25 lut 2026, 23:25 UTC

Earnings

Trip.com FY Rev CNY62.4B, Up 17% >TCOM

25 lut 2026, 23:25 UTC

Earnings

Trip.com FY Net CNY33.3B Vs. Net CNY17.1B >TCOM

25 lut 2026, 23:25 UTC

Earnings

Trip.com FY EPS CNY47.67 >TCOM

25 lut 2026, 23:06 UTC

Earnings

Correction to Nvidia Fourth Quarter Results Article -- WSJ

25 lut 2026, 23:01 UTC

Earnings

Nvidia Beats Back Bubble Fears With Record $68 Billion Sales in Fourth Quarter -- 3rd Update

25 lut 2026, 23:00 UTC

Market Talk

Earnings

Global Equities Roundup: Market Talk

25 lut 2026, 23:00 UTC

Market Talk

Earnings

Nvidia: Chinese Competitors Pose Risk to U.S. Dominance in AI -- Market Talk

25 lut 2026, 22:56 UTC

Market Talk

Earnings

Nvidia CEO Says Customers Can't Grow Revenue Without Compute -- Market Talk

25 lut 2026, 22:43 UTC

Earnings

Acquisitions, Mergers, Takeovers

Paramount Streaming Revenue Rises, but TV Segment Faces Headwinds -- WSJ

25 lut 2026, 22:40 UTC

Market Talk

Earnings

Nvidia Says Agentic AI Has Reached Inflection Point -- Market Talk

25 lut 2026, 22:40 UTC

Earnings

Karoon Energy Says Search for New CFO Well Advanced

25 lut 2026, 22:39 UTC

Earnings

Karoon Energy Says CFO Ray Church to Leave Company

25 lut 2026, 22:39 UTC

Earnings

Karoon Energy Says On-Market Share Buyback Program Ongoing at Moderated Level

25 lut 2026, 22:38 UTC

Earnings

Karoon Energy Says Guidance for 2026 Key Metrics Unchanged

Peer Comparison

Price change

Vetoquinol SA Forecast

Rating Consensus

By TipRanks

0 ratings

Buy

Hold

Sell

Based on 0 analysts giving stock ratings to Vetoquinol SA - Dist in the past 3 months.

Technical Score

By Trading Central

72.6 / 75.1Support & Resistance

Recent bearish events outweigh bullish events.

All events are bearish.

Sentiment

By Acuity

167 / 351 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Vetoquinol SA

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.